➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
McKesson
Moodys
Merck
Express Scripts

Last Updated: July 29, 2021

DrugPatentWatch Database Preview

Details for Patent: 9,968,659


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,968,659 protect, and when does it expire?

Patent 9,968,659 protects SAXENDA and VICTOZA and is included in two NDAs.

Protection for SAXENDA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fourteen patent family members in fourteen countries.

Summary for Patent: 9,968,659
Title:Liraglutide in cardiovascular conditions
Abstract: The present invention relates to the GLP-1 receptor agonist liraglutide for use in medicine.
Inventor(s): Rasmussen; Soeren (Copenhagen, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:15/401,651
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,968,659
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 9,968,659

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novo SAXENDA liraglutide recombinant SOLUTION;SUBCUTANEOUS 206321-001 Dec 23, 2014 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Novo Nordisk Inc VICTOZA liraglutide recombinant SOLUTION;SUBCUTANEOUS 022341-001 Jan 25, 2010 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,968,659

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2017225841 ⤷  Try it Free
Brazil 112018067344 ⤷  Try it Free
Canada 3013532 ⤷  Try it Free
Chile 2018002515 ⤷  Try it Free
China 108778317 ⤷  Try it Free
European Patent Office 3423082 ⤷  Try it Free
Israel 261169 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
McKinsey
Medtronic
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.